Literature DB >> 3799657

Histoplasmosis in patients with the acquired immune deficiency syndrome.

W Mandell, D M Goldberg, H C Neu.   

Abstract

Five patients with disseminated histoplasmosis are reviewed. Four of five had the acquired immune deficiency syndrome (AIDS) and one was receiving steroid therapy. All were immigrants to the United States from Puerto Rico, the Dominican Republic, or South America, and none had a history of travel to regions of the United States where Histoplasma is endemic. Histoplasma complement fixation titers to mycelial antigen were not demonstrable in three of three patients in whom they were measured. Of the four patients with AIDS, Histoplasma capsulatum was isolated from bone marrow aspirates in two patients and from lymph node and liver biopsy specimens in one patient each. One of the bone marrow specimens showed organisms on Gomori-methenamine silver stain. In the other three cases, results of staining were falsely negative and diagnosis awaited culture results weeks later. Amphotericin B therapy resulted in rapid clinical improvement in the three patients that were treated. Intravenous therapy was followed by treatment with oral ketoconazole. Follow-up has not been long enough to determine the ultimate efficacy of ketoconazole. Disseminated histoplasmosis should be considered in all patients from the Caribbean or South America with AIDS or who are receiving immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3799657     DOI: 10.1016/0002-9343(86)90390-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  16 in total

Review 1.  Histoplasmosis: a clinical and laboratory update.

Authors:  Carol A Kauffman
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

2.  Gonarthritis as only manifestation of chronic disseminated histoplasmosis.

Authors:  A C Van der Schee; B A Dinkla; J J Festen
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 3.  Fungal infections of the immunocompromised host: clinical and laboratory aspects.

Authors:  C E Musial; F R Cockerill; G D Roberts
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

Review 4.  Diagnosis and management of histoplasmosis.

Authors:  L J Wheat
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

5.  Typing of Histoplasma capsulatum by restriction fragment length polymorphisms in a nuclear gene.

Authors:  E J Keath; G S Kobayashi; G Medoff
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

6.  Histoplasmosis in individuals with acquired immunodeficiency syndrome (AIDS): report of six cases with cutaneous-mucosal involvement.

Authors:  A A Machado; I C Coelho; A M Roselino; E S Trad; J F Figueiredo; R Martinez; J C de Costa
Journal:  Mycopathologia       Date:  1991-07       Impact factor: 2.574

7.  Transfer of protective immunity in murine histoplasmosis by a CD4+ T-cell clone.

Authors:  R Allendoerfer; D M Magee; G S Deepe; J R Graybill
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

8.  Antigenicity and immunogenicity of an extract from the cell wall and cell membrane of Histoplasma capsulatum yeast cells.

Authors:  A M Gómez; J C Rhodes; G S Deepe
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

Review 9.  Histoplasma capsulatum, lung infection and immunity.

Authors:  Michael C Horwath; Roger A Fecher; George S Deepe
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

10.  Histoplasma capsulatum proteome response to decreased iron availability.

Authors:  Michael S Winters; Daniel S Spellman; Qilin Chan; Francisco J Gomez; Margarita Hernandez; Brittany Catron; Alan G Smulian; Thomas A Neubert; George S Deepe
Journal:  Proteome Sci       Date:  2008-12-24       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.